Troutman Pepper Hamilton Sanders LLP advised Inhibikase Therapeutics, Inc. on the deal. Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a clinical-stage pharmaceutical company developing therapeutics for Parkinson’s Disease…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now